tumor

January 22, 2021, by NCI Staff Obesity may render T cells (green)…

“This is not the meeting where you’re going to hear the readouts of late-stage clinical trials. Rather, it is about scientific discovery, immunological mechanisms, and basic biology—the essential grist that will enable…

The third day of CICON18 explored cutting-edge strategies to identify and target the mutated markers that distinguish cancer cells. SESSION 5: Novel Vaccine Platforms and Combinations Filling in for Robert Schreiber,…

The second day of CICON19 kicked off with Johns Hopkins University’s Elizabeth M. Jaffee, M.D., one of the recipients of the 2019 William B. Coley Award, who gave the annual Coley lecture. Jaffee, a member of the CRI…

The third day of CICON19 opened with session 7 devoted to tumor antigens, with a talk by Yardena Samuels, Ph.D., of the Weizmann Institute of Science (Israel), who discussed her work covering a variety of issues relating…

It is estimated that 1 in 161 individuals born today will develop brain or nervous system cancer at some point in their lives. Although significant advances have been made in understanding the biology of these cancers—as…

For any tumor that's accessible by scalpel, physicians often take what's called a biopsy, snipping away a tiny portion of the mass. From that scrap, doctors glean as much information about the tumor as they can through two…